Venus Remedies Share Price Jumps 14.38% After Net Profit Jumps 473.5% YoY

Chandigarh, November 11: Venus Remedies share price is witnessing a heavy rally today after it reported a strong financial performance for the quarter ended September 30, 2025. As of 11:30 AM, Venus Remedies share price is up by 14.38%, or 67.45 points, and is trading at ₹536.40. Until now, the Venus Remedies shares have traded within a range of ₹553.20 and ₹528.50. The current traded volume for Venus Remedies stock stands at 5.50 lakh shares, with the company’s market cap at ₹627 crore. The shares have their 52-week high at ₹567.80 and their 52-week low at ₹270.25.

Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is an Indian company that manufactures a wide range of pharmaceuticals. It specialises in critical care, oncology, and anti-infective solutions. It is a major manufacturer of meropenem antibiotics. The company was established in 1989, and is headquartered in Chandigarh.

Venus Remedies Q2FY26 Financial Highlights

In Q2 FY26, the company reported consolidated revenue from operations of ₹192.75 crore, which is an increase of 13.3% year-on-year compared to ₹170.10 crore in Q2 FY25, and a 40.6% growth quarter-on-quarter from ₹137.18 crore in Q1 FY26. The profit after tax (PAT) for the quarter stood at ₹20.13 crore, higher compared to ₹3.51 crore in Q2 FY25, with a sharp YoY jump of 473.5%. On a sequential basis, PAT also more than doubled, rising 109.7% from ₹9.60 crore in Q1 FY26.

Investor Takeaway for Venus Remedies

Venus Remedies has reported a strong financial performance for the quarter ended September 30. It saw growth across all key metrics, with a significant 473.5% rise in its net profit to ₹20.13 crore. The strong financial result has positively affected investor sentiments, leading to a rise in the share price. It remains to be seen if the shares can sustain this performance in the coming days, and end the week in the green.

REF: https://nsearchives.nseindia.com/corporate/VENUSREM_10112025184023_BM_OutcomeSep2025_Allsigned.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations